Viridian Therapeutics
VRDN
#5061
Rank
โ‚ฌ1.19 B
Marketcap
14,71ย โ‚ฌ
Share price
3.93%
Change (1 day)
-13.66%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -4,57ย โ‚ฌ

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -4,51ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,73ย โ‚ฌ an increase over its 2021 EPS that were of -7,02ย โ‚ฌ.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,57ย โ‚ฌ22.51%
2022-3,73ย โ‚ฌ-46.83%
2021-7,02ย โ‚ฌ-73.94%
2020-26,95ย โ‚ฌ44.73%
2019-18,62ย โ‚ฌ22.94%
2018-15,14ย โ‚ฌ-27.33%
2017-20,84ย โ‚ฌ-91.47%
2016-244,26ย โ‚ฌ-19.17%
2015-302,20ย โ‚ฌ-75.48%
2014-1.232ย โ‚ฌ582.47%
2013-180,59ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,02ย โ‚ฌ-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA